Cargando…
Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome
BACKGROUND: In non-ST-segment elevation acute coronary syndrome (ACS), the likelihood of adverse events should be estimated. Guidelines recommend risk stratification models for that purpose. The Dante Pazzanese risk score (DANTE score) is a simple risk stratification model composed with the followin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032298/ https://www.ncbi.nlm.nih.gov/pubmed/23949327 http://dx.doi.org/10.5935/abc.20130163 |
_version_ | 1782317625465896960 |
---|---|
author | dos Santos, Elizabete Silva Minuzzo, Luiz de Souza, Roberta Timerman, Ari |
author_facet | dos Santos, Elizabete Silva Minuzzo, Luiz de Souza, Roberta Timerman, Ari |
author_sort | dos Santos, Elizabete Silva |
collection | PubMed |
description | BACKGROUND: In non-ST-segment elevation acute coronary syndrome (ACS), the likelihood of adverse events should be estimated. Guidelines recommend risk stratification models for that purpose. The Dante Pazzanese risk score (DANTE score) is a simple risk stratification model composed with the following variables: age increase (0 to 9 points); history of diabetes mellitus (2 points) or stroke (4 points); no use of angiotensin-converting-enzyme inhibitor (1 point); creatinine elevation (0 to 10 points); combination of troponin elevation and ST-segment depression (0 to 4 points). OBJECTIVE: To validate the DANTE score in patients with non-ST-segment elevation ACS. METHODS: Prospective, observational study including 457 patients, from September 2009 to October 2010. The patients were grouped in risk categories according to the original model score as follows: very low; low; intermediate; and high. The predictive ability of the score was assessed by using C-statistics. RESULTS: The sample comprised 291 (63.7%) men, the mean age being 62.1 years (SD=11.04). The event death or (re) infarction in 30 days was observed in 17 patients (3.7%). Progressive increase in the proportion of events was observed as the score increased: very low risk = 0.0%; low risk = 3.9%; intermediate risk = 10.9%; high risk = 60.0%; p < 0.0001. C-statistics was 0.87 (95% CI: 0.81-0.94; p < 0.0001). CONCLUSION: DANTE score showed an excellent capacity to predict the specific events, and can be incorporated to the prognostic assessment of patients with non-ST-segment elevation ACS. |
format | Online Article Text |
id | pubmed-4032298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Sociedade Brasileira de Cardiologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-40322982014-05-27 Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome dos Santos, Elizabete Silva Minuzzo, Luiz de Souza, Roberta Timerman, Ari Arq Bras Cardiol Original Article BACKGROUND: In non-ST-segment elevation acute coronary syndrome (ACS), the likelihood of adverse events should be estimated. Guidelines recommend risk stratification models for that purpose. The Dante Pazzanese risk score (DANTE score) is a simple risk stratification model composed with the following variables: age increase (0 to 9 points); history of diabetes mellitus (2 points) or stroke (4 points); no use of angiotensin-converting-enzyme inhibitor (1 point); creatinine elevation (0 to 10 points); combination of troponin elevation and ST-segment depression (0 to 4 points). OBJECTIVE: To validate the DANTE score in patients with non-ST-segment elevation ACS. METHODS: Prospective, observational study including 457 patients, from September 2009 to October 2010. The patients were grouped in risk categories according to the original model score as follows: very low; low; intermediate; and high. The predictive ability of the score was assessed by using C-statistics. RESULTS: The sample comprised 291 (63.7%) men, the mean age being 62.1 years (SD=11.04). The event death or (re) infarction in 30 days was observed in 17 patients (3.7%). Progressive increase in the proportion of events was observed as the score increased: very low risk = 0.0%; low risk = 3.9%; intermediate risk = 10.9%; high risk = 60.0%; p < 0.0001. C-statistics was 0.87 (95% CI: 0.81-0.94; p < 0.0001). CONCLUSION: DANTE score showed an excellent capacity to predict the specific events, and can be incorporated to the prognostic assessment of patients with non-ST-segment elevation ACS. Sociedade Brasileira de Cardiologia 2013-09 /pmc/articles/PMC4032298/ /pubmed/23949327 http://dx.doi.org/10.5935/abc.20130163 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article dos Santos, Elizabete Silva Minuzzo, Luiz de Souza, Roberta Timerman, Ari Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome |
title | Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment
Elevation Acute Coronary Syndrome |
title_full | Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment
Elevation Acute Coronary Syndrome |
title_fullStr | Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment
Elevation Acute Coronary Syndrome |
title_full_unstemmed | Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment
Elevation Acute Coronary Syndrome |
title_short | Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment
Elevation Acute Coronary Syndrome |
title_sort | prospective validation of the dante pazzanese risk score in non-stsegment
elevation acute coronary syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032298/ https://www.ncbi.nlm.nih.gov/pubmed/23949327 http://dx.doi.org/10.5935/abc.20130163 |
work_keys_str_mv | AT dossantoselizabetesilva prospectivevalidationofthedantepazzaneseriskscoreinnonstsegmentelevationacutecoronarysyndrome AT minuzzoluiz prospectivevalidationofthedantepazzaneseriskscoreinnonstsegmentelevationacutecoronarysyndrome AT desouzaroberta prospectivevalidationofthedantepazzaneseriskscoreinnonstsegmentelevationacutecoronarysyndrome AT timermanari prospectivevalidationofthedantepazzaneseriskscoreinnonstsegmentelevationacutecoronarysyndrome |